Hi people!
On March,15, after fews weeks feeling fever and nocturnal sweating, it was revealed a white blood count of 239 and hb 8,7. I started taken hydrea until March, 29 when the first qualitative PCR was available and showed the BCR-ABL fusion isoform b3a2-p210 confirming the CML diagnostic. I started taken Imatinibe 400 mg/day, since March, 30 and stopped Hydrea.
It was supposed to be made a quantitative PCR test 3 months after the starting treatment with Imatinibe. However, it was, wrongly, done a (second) qualitative RT-PCR on last June showing isoforms e1a2-p190 and b3a2-p210. Both tests were done in the same lab.
Is there any relevant info for the purpose of the treatment that it was dsicovered a second isoform in the second qualitative test?
I achieved CHR in 35 days after the Imatinibe dosage of 400 mg/day. The result of the quantitative PCR (p210 isoform), done in early July, showed a MR2 (2 log) reduction. The IS was 0,12305%, which is good.
My second question is about the need for the quantitative PCR for the p190 isoform (if applicable). The quantitative PCR was done in another lab.
Regards, SIlas